Current problems and the future of antiretroviral drug trials

被引:29
作者
Lange, JMA
机构
[1] Natl. AIDS Therapy Evaluation Center, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam
[2] Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb
关键词
D O I
10.1126/science.276.5312.548
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
[No abstract available]
引用
收藏
页码:548 / 550
页数:3
相关论文
共 38 条
[1]  
BOUCHER CAB, 1994, VIRAL VARIATION THER
[2]   SC-52151, A NOVEL INHIBITOR OF THE HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE [J].
BRYANT, M ;
GETMAN, D ;
SMIDT, M ;
MARR, J ;
CLARE, M ;
DILLARD, R ;
LANSKY, D ;
DECRESCENZO, G ;
HEINTZ, R ;
HOUSEMAN, K ;
REED, K ;
STOLZENBACH, J ;
TALLEY, J ;
VAZQUEZ, M ;
MUELLER, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (10) :2229-2234
[3]  
CAMERON B, 1996, 3 C RETR OPP INF WAS
[4]   HIV POPULATION-DYNAMICS IN-VIVO - IMPLICATIONS FOR GENETIC-VARIATION, PATHOGENESIS, AND THERAPY [J].
COFFIN, JM .
SCIENCE, 1995, 267 (5197) :483-489
[5]   IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS [J].
CONDRA, JH ;
SCHLEIF, WA ;
BLAHY, OM ;
GABRYELSKI, LJ ;
GRAHAM, DJ ;
QUINTERO, JC ;
RHODES, A ;
ROBBINS, HL ;
ROTH, E ;
SHIVAPRAKASH, M ;
TITUS, D ;
YANG, T ;
TEPPLER, H ;
SQUIRES, KE ;
DEUTSCH, PJ ;
EMINI, EA .
NATURE, 1995, 374 (6522) :569-571
[6]   HIGH-CONCENTRATIONS OF RECOMBINANT SOLUBLE CD4 ARE REQUIRED TO NEUTRALIZE PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES [J].
DAAR, ES ;
LI, XL ;
MOUDGIL, T ;
HO, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (17) :6574-6578
[7]   ALTERNATING NEVIRAPINE AND ZIDOVUDINE TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PERSONS DOES NOT PROLONG NEVIRAPINE ACTIVITY [J].
DEJONG, MD ;
LOEWENTHAL, M ;
BOUCHER, CAB ;
VANDERENDE, I ;
HALL, D ;
SCHIPPER, P ;
IMRIE, A ;
WEIGEL, HM ;
KAUFFMANN, RH ;
KOSTER, R ;
SEVILLE, P ;
ROCKLIN, R ;
COOPER, DA ;
LANGE, JMA .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (06) :1346-1350
[8]  
EMINI EA, 1996, 3 C RETR OPP INF WAS
[9]  
FOUDRAINE N, 1997, 4 C RETR OPP INF WAS
[10]  
GEORGES DL, 1995, 2 NAT C HUM RETR REL